SCHEMBL17312902

SCHEMBL17312902

CC(=O)CCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=O)C(=O)Nc1ccc(CO)cc1)C(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FURIN P09958 5/20 0.41
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
NPY5R Q15761 4/20 0.38
NPY4R P50391 4/20 0.38
NPY1R P25929 3/20 0.38
NPY2R P49146 1/20 0.38
POLB P06746 2/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20839656 0.95 NPY5R (0.42) FURINHTTSMN1; SMN2NPY5RNPY4R
SCHEMBL24270749 0.92 FURIN (0.43) FURINHTTSIRT1
SCHEMBL24864421 0.90 NPY5R (0.40) FURINHTTNPY5RNPY4RNPY1R
SCHEMBL14978855 0.90 NMT2 (0.45) FURINNPY5RNPY4RNPY1RNPY2R
SCHEMBL23355149 0.90 CTSL (0.42) FURINHTTNPY5RNPY4RNPY1R
SCHEMBL15692124 0.90 NMT2 (0.45) FURINNPY5RNPY4RNPY1RNPY2R
SCHEMBL23943639 0.90 FURIN (0.44) FURINHTTSMN1; SMN2NPY5RNPY4R
SCHEMBL16847753 0.89 FURIN (0.43) FURINHTTSMN1; SMN2POLBLMNA
SCHEMBL22054636 0.89 SIRT5 (0.42) FURINHTTSMN1; SMN2MAP1LC3BSIRT1
SCHEMBL21607790 0.88 FURIN (0.42) FURINHTTSMN1; SMN2NPY5RNPY4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2928902-B1 CONJUGATE COMPOUNDS VICTORIA LINK LTD (NZ) 2019-07-17 EP disclosed
US-20150352219-A1 CONJUGATE COMPOUNDS VICTORIA LINK LIMITED (NZ) 2015-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150352219-A1 CONJUGATE COMPOUNDS SGMS1, SGMS2, ENPP2 FURIN 290/4885HTT 3646/4885SMN1; SMN2 2136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.